4.3 Article

Association of Ornithine Transcarbamylase Gene Polymorphisms With Hypertension and Coronary Artery Vasomotion

Journal

AMERICAN JOURNAL OF HYPERTENSION
Volume 22, Issue 9, Pages 993-1000

Publisher

OXFORD UNIV PRESS
DOI: 10.1038/ajh.2009.110

Keywords

-

Funding

  1. Conseil Regional Nord-Pas-de-Calais
  2. Institut National de la Sante et de la Recherche Medicale (Inserm).
  3. Ministere de I'Enseignement Superieur et de la Recherche Scientifique, Algeria
  4. Centre National des Oeuvres Universitaires et Scolaires.
  5. Alzheimer's association [IIRG-06-25487]
  6. France Alzheimer Association
  7. Conseil Regional du Nord-Pas de Calais
  8. Fondation pour la Recherche Medicale, ONIVINS
  9. Parke-Davis Laboratory
  10. Mutuelle Generale de I'Education Nationale
  11. Reseau National de Sante Publique
  12. Direction Generale de La Sante, Inserm
  13. Institut Pasteur de Lille
  14. Universite de Lille 2
  15. Unite d'Evaluation du Centre Hospitalier et Universitaire de Lille (France).
  16. EISAI Co (France).
  17. Direction de la Recherche et des Etudes Doctorales de Lille
  18. Centre Hospitalier Universitaire de Lille, Inserm,
  19. Institut Pasteur de Lille (France).

Ask authors/readers for more resources

BACKGROUND Previous studies have suggested that the activity of enzymes involved in the urea cycle may modulate nitric oxide (NO) production, arterial vasomotion, and hypertension. Our aim was to determine whether hypertension and coronary vasomotion could be associated with polymorphisms within the ornithine transcarbamylase (OTC) gene, located on chromosome X and coding for a key-enzyme of the urea cycle. METHODS Among 11 OTC polymorphisms that were originally selected from databases, the tag single-nucleotide polymorphism (SNP) rs5963409 and the independent SNP rs1800321 were tested for association with hypertension in two independent population samples recruited in Northern (Multinational MONItoring of and determinants in CArdiovascular disease (MONICA) study, n = 1,138) and Western (Etude du Vieillissement Arteriel (EVA) study, n = 1,166) France. The vasomotor response of coronary arteries to methylergonovine maleate and isosorbide dinitrate was also evaluated in an independent sample (the vasomotion study, n = 121). RESULTS In males, the frequency of the rs5963409 minor allele was consistently higher in hypertensive (HT) than in normotensive subjects in the MONICA and EVA studies. In the combined sample, the rs5963409 minor allele was associated with an increased risk of hypertension (odds ratio (OR) (95% confidence interval (CI)) = 1.45 (1.10-1.90); P = 0.008). This association was independent of classical confounding factors. Consistently, rs5963409 minor allele was associated with a greater susceptibility to vasoconstriction in response to methylergonovine maleate (P = 0.0072). In contrast, no significant association between rs5963409 and hypertension could be detected in females. CONCLUSION Our results suggest that the OTC rs5963409 polymorphism may be associated with hypertension and coronary vasomotion in males. Am J hypertens 2009; 22:993-1000 (C) 2009 American Journal of Hypertension, Ltd.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Obstetrics & Gynecology

Profiles of copper intrauterine devices and levonorgestrel intrauterine systems users in France in 2019: A national observational population-based study

Noemie Roland, Berangere Baricault, Rosemary Dray-Spira, Alain Weill, Lise Duranteau, Mahmoud Zureik

Summary: This study assessed the user profiles and continuation rates of Cu-IUDs and LNG-IUSs in France in 2019. The findings indicate that LNG-IUS use is associated with being aged 35-44, receiving a prescription from a gynecologist, and having a gynecological history. Cu-IUDs have a higher continuation rate compared to LNG-IUSs.

INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2023)

Article Geriatrics & Gerontology

Genetically downregulated Interleukin-6 signalling is associated with a lower risk of frailty

Niki Mourtzi, Mariosk Georgakis, Eva Ntanasi, Alexandros Hatzimanolis, Alfredo Ramirez, Stephanie Heilmann-Heimbach, Benjamin Grenier-Boley, Jeanc Lambert, Mary Yannakoulia, Mary Kosmidis, Efthimios Dardiotis, Giorgos Hadjigeorgiou, Paraskevi Sakka, Nikolaos Scarmeas

Summary: This study found a potential causal effect of IL-6 signaling on frailty, with downregulation of IL-6 levels associated with a reduced risk of frailty. The results support the critical role of IL-6 pathway in frailty pathogenesis.

AGE AND AGEING (2023)

Article Multidisciplinary Sciences

Heritable defects in telomere and mitotic function selectively predispose to sarcomas

Mandy L. Ballinger, Swetansu Pattnaik, Piyushkumar A. Mundra, Milita Zaheed, Emma Rath, Peter Priestley, Jonathan Baber, Isabelle Ray-Coquard, Nicholas Isambert, Sylvain Causeret, Winette T. A. van der Graaf, Ajay Puri, Florence Duffaud, Axel Le Cesne, Beatrice Seddon, Coonoor Chandrasekar, Joshua D. Schiffman, Andrew S. Brohl, Paul A. James, Jean-Emmanuel Kurtz, Nicolas Penel, Ola Myklebost, Leonardo A. Meza-Zepeda, Hilda Pickett, Maya Kansara, Nicola Waddell, Olga Kondrashova, John Pearson, Andrew P. Barbour, Shuai Li, Tuong L. Nguyen, Diane Fatkin, Robert M. Graham, Eleni Giannoulatou, Melissa J. Green, Warren Kaplan, Shyamsundar Ravishankar, Joseph Copty, Joseph E. Powell, Edwin Cuppen, Kristel van Eijk, Jan Veldink, Jin-Hee Ahn, Jeong Eun Kim, R. Lor Randall, Kathy Tucker, Ian Judson, Rajiv Sarin, Thomas Ludwig, Emmanuelle Genin, Jean-Francois Deleuze, Michelle Haber, Glenn Marshall, Murray J. Cairns, Jean-Yves Blay, David M. Thomas

Summary: Cancer genetics has focused on epithelial malignancies, but this study explores specific pathways related to sarcomas, rare malignancies derived from embryonic mesoderm. Germline sequencing of sporadic cases and healthy controls reveals two sarcoma-specific pathways involved in mitotic and telomere functions. Centrosome gene variants are linked to specific tumors, while heritable defects in the shelterin complex increase susceptibility to sarcomas, melanomas, and thyroid cancers. These findings highlight the role of heritable defects in mitotic and telomere biology in sarcoma risk.

SCIENCE (2023)

Article Clinical Neurology

Genetic propensity for cerebral amyloidosis and risk of mild cognitive impairment and Alzheimer's disease within a cognitive reserve framework

Niki Mourtzi, Sokratis Charisis, Angeliki Tsapanou, Eva Ntanasi, Alexandros Hatzimanolis, Alfredo Ramirez, Stefanie Heilmann-Heimbach, Benjamin Grenier-Boley, Jean-Charles Lambert, Mary Yannakoulia, Mary Kosmidis, Efthimios Dardiotis, Georgiios Hadjigeorgiou, Paraskevi Sakka, Marios Georgakis, Stern Yaakov, Nikolaos Scarmeas

Summary: A polygenic risk score (PRSA beta 42) proxying AD pathology was constructed, and its association with incident AD/aMCI and the influence of cognitive reserve (CR) on this association were investigated. The results showed that higher PRSA beta 42 and CR were associated with increased and decreased risk of AD/aMCI, respectively. An additive interaction between PRSA beta 42 and CR was observed, and the protective effect of high CR was only evident in individuals with high PRSA beta 42 levels.

ALZHEIMERS & DEMENTIA (2023)

Article Oncology

Severe Hypersensitivity Reactions at Biosimilar versus Originator Rituximab Treatment Initiation, Switch and Over Time: A Cohort Study on the French National Health Data System

Hugo Jourdain, Lea Hoisnard, Emilie Sbidian, Mahmoud Zureik

Summary: This study aimed to assess the association between biosimilar and originator rituximab injections and hypersensitivity reactions. The results showed no increased risk of hypersensitivity reactions with biosimilar use, both at initiation and over time.

BIODRUGS (2023)

Review Biochemistry & Molecular Biology

Step by step: towards a better understanding of the genetic architecture of Alzheimer's disease

Jean-Charles Lambert, Alfredo Ramirez, Benjamin Grenier-Boley, Celine Bellenguez

Summary: Alzheimer's disease (AD) has a significant genetic component, and recent advancements in genome-wide association studies and collaborative research have improved our understanding of this component. The identification of various chromosomal regions and causal genes associated with AD risk has confirmed the involvement of major pathophysiological pathways and revealed new perspectives. Furthermore, large-scale sequencing projects have shown the impact of rare variants on AD risk. Translational research is now disseminating this knowledge, particularly through the development of genetic risk/polygenic risk scores to identify high-risk or low-risk subpopulations for AD. Further research and improvement in understanding the genetic component of AD are necessary, and genetics may ultimately redefine the boundaries and relationships between different neurodegenerative diseases.

MOLECULAR PSYCHIATRY (2023)

Article Psychiatry

Modifications of the endosomal compartment in fibroblasts from sporadic Alzheimer's disease patients are associated with cognitive impairment

Laura Xicota, Julien Lagarde, Fanny Eysert, Benjamin Grenier-Boley, Isabelle Rivals, Alexandra Botte, Sylvie Forlani, Sophie Landron, Clement Gautier, Cecilia Gabriel, Michel Bottlaender, Jean-Charles Lambert, Mounia Chami, Marie Sarazin, Marie-Claude Potier

Summary: Morphological alterations in the endosomal compartment were observed in post-mortem brains of Alzheimer's disease (AD) patients and Down syndrome (DS) patients who have a high risk of AD. In this study, fibroblasts from a well-characterized cohort of AD patients were analyzed to investigate the association between endosomal compartment and AD. The results revealed an increased volume of EEA1-positive puncta in fibroblasts from AD patients, which correlated with amyloid deposition in the brain and cognitive decline. Genetic risk factors for AD were also identified. In conclusion, the endosomal compartment in fibroblasts may serve as a peripheral cellular biomarker for amyloid deposition and cognitive decline in AD.

TRANSLATIONAL PSYCHIATRY (2023)

Article Medicine, General & Internal

Genetic Associations Between Modifiable Risk Factors and Alzheimer Disease

Jiao Luo, Jesper Qvist Thomassen, Celine Bellenguez, Benjamin Grenier-Boley, Itziar de Rojas, Atahualpa Castillo, Kayenat Parveen, Fahri Kuecuekali, Aude Nicolas, Oliver Peters, Anja Schneider, Martin Dichgans, Dan Rujescu, Norbert Scherbaum, Deckert Juergen, Steffi Riedel-Heller, Lucrezia Hausner, Laura Molina Porcel, Emrah Duezel, Timo Grimmer, Jens Wiltfang, Stefanie Heilmann-Heimbach, Susanne Moebus, Thomas Tegos, Nikolaos Scarmeas, Jordi Clarimon, Fermin Moreno, Jordi Perez-Tur, Maria J. Bullido, Pau Pastor, Raquel Sanchez-Valle, Victoria Alvarez, Merce Boada, Pablo Garcia-Gonzalez, Raquel Puerta, Pablo Mir, Luis M. Real, Gerard Pinol-Ripoll, Jose Maria Garcia-Alberca, Jose Luis Royo, Eloy Rodriguez-Rodriguez, Hilkka Soininen, Teemu Kuulasmaa, Alexandre de Mendonca, Shima Mehrabian, Jakub Hort, Martin Vyhnalek, Sven van der Lee, Caroline Graff, Goran Papenberg, Vilmantas Giedraitis, Anne Boland, Delphine Bacq-Daian, Jean-Francois Deleuze, Gael Nicolas, Carole Dufouil, Florence Pasquier, Olivier Hanon, Stephanie Debette, Edna Gruenblatt, Julius Popp, Luisa Benussi, Daniela Galimberti, Beatrice Arosio, Patrizia Mecocci, Vincenzo Solfrizzi, Lucilla Parnetti, Alessio Squassina, Lucio Tremolizzo, Barbara Borroni, Benedetta Nacmias, Sandro Sorbi, Paolo Caffarra, Davide Seripa, Innocenzo Rainero, Antonio Daniele, Carlo Masullo, Gianfranco Spalletta, Julie Williams, Philippe Amouyel, Frank Jessen, Patrick Kehoe, Tsolaki Magda, Giacomina Rossi, Pascual Sanchez-Juan, Kristel Sleegers, Martin Ingelsson, Ole A. Andreassen, Mikko Hiltunen, Cornelia Van Duijn, Rebecca Sims, Wiesje van der Flier, Agustin Ruiz, Alfredo Ramirez, Jean-Charles Lambert, Ruth Frikke-Schmidt

Summary: This genetic association study identifies novel genetic associations between high HDL cholesterol concentrations and high systolic blood pressure with increased risk of AD, potentially inspiring new drug targeting and improved prevention implementation.

JAMA NETWORK OPEN (2023)

Article Multidisciplinary Sciences

Multiancestry analysis of the HLA locus in Alzheimer's and Parkinson's diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes

Yann Le Guen, Guo Luo, Aditya Ambati, Vincent Damotte, Iris Jansen, Eric Yu, Aude Nicolas, Itziar de Rojasj, Thiago Peixoto Leal, Akinori Miyashita, Celine Bellenguez, Michelle Mulan Lian, Kayenat Parveen, Takashi Morizono, Hyeonseul Park, Benjamin Grenier-Boley, Tatsuhiko Naito, Fahri Kucukali, Seth D. Talyansky, Selina Maria Yogeshwar, Vicente Sempere, Wataru Satake, Victoria Alvarez, Beatrice Arosio, Michael E. Belloy, Luisa Benussi, Anne Boland, Barbara Borroni, Maria J. Bullido, Paolo Caffarra, Jordi Clarimon, Antonio Daniele, Daniel Darling, Stephanie Debette, Jean-Francois Deleuze, Martin Dichgans, Carole Dufouil, Emmanuel During, Emrah Duzel, Daniela Galimberti, Guillermo Garcia-Ribas, Jose Maria Garcia-Alberca, Pablo Garcia-Gonzalez, Vilmantas Giedraitis, Oliver Goldhardt, Caroline Graff, Edna Grunblatt, Olivier Hanon, Lucrezia Hausner, Stefanie Heilmann-Heimbach, Henne Holstege, Jakub Hort, Yoo Jin Jung, Deckert Jurgen, Silke Kern, Teemu Kuulasmaa, Kun Ho Lee, Ling Lin, Carlo Masullo, Patrizia Mecocci, Shima Mehrabian, Alexandre de Mendonca, Merce Boada, Pablo Mir, Susanne Moebus, Fermin Moreno, Benedetta Nacmias, Gael Nicolas, Shumpei Niida, Borge G. Nordestgaard, Goran Papenberg, Janne Papma, Lucilla Parnetti, Florence Pasquier, Pau Pastor, Oliver Peters, Yolande A. L. Pijnenburg, Gerard Pinol-Ripoll, Julius Popp, Laura Molina Porcel, Raquel Puertaj Jordi Perez-Tur, Innocenzo Rainero, Inez Ramakers, Luis M. Real, Steffi Riedel-Heller, Eloy Rodriguez-Rodriguez, Owen A. Ross, Jose Luis Royo, Dan Rujescu, Nikolaos Scarmeas, Philip Scheltens, Norbert Scherbaum, Anja Schneider, Davide Seripa, Ingmar Skoog, Vincenzo Solfrizzi, Gianfranco Spalletta, Alessio Squassina, John van Swieten, Raquel Sanchez-Valle, Eng-King Tan, Thomas Tegos, Charlotte Teunissen, Jesper Qvist Thomassen, Lucio Tremolizzo, Martin Vyhnalek, Frans Verhey, Margda Waern, Jens Wiltfang, Jing Zhangc, Henrik Zetterberg, Kaj Blennow, Zihuai He, Julie Williams, Philippe Amouyel, Frank Jessen, Patrick G. Kehoe, Ole A. Andreassen, Cornelia Van Duin, Magda Tsolaki, Pascual Sanchez-Juan, Ruth Frikke-Schmidt, Kristel Sleegers, Tatsushi Todau, Anna Zettergren, Martin Ingelsson, Yukinori Okada, Giacomina Rossi, Mikko Hiltunen, Jungsoo Gim, Kouichi Ozaki, Rebecca Sims, Jia Nee Foo, Wiesje van der Fliere, Takeshi Ikeuchi, Alfredo Ramirez, Ignacio Mata, Agustin Ruiz, Ziv Gan-Or, Jean-Charles Lambert, Michael D. Greicius, Emmanuel Mignot

Summary: We analyzed the HLA associations in individuals with Parkinson's disease and Alzheimer's disease across different ancestry groups and found that these two diseases share a common protective association at the HLA locus. Fine-mapping showed that specific subtypes of HLA-DRB1*04 were responsible for this association, with HLA-DRB1*04:04 and HLA-DRB1*04:07 showing the strongest association. This protective effect was also associated with decreased neurofibrillary tangles in the brain and reduced levels of tau protein in cerebrospinal fluid.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)

Article Medicine, General & Internal

Drug survival and safety of biosimilars and originator adalimumab in the treatment of psoriasis: a multinational cohort study

Duc Binh Phan, Hugo Jourdain, Alicia Gonzalez-Quesada, Mahmoud Zureik, Raquel Rivera-Diaz, Antonio Sahuquillo-Torralba, Miguel Angel Descalzo-Gallego, Mark Lunt, Ignacio Garcia-Doval, Emilie Sbidian, R. B. Warren, Zenas Z. N. Yiu

Summary: This study aims to compare the safety and drug survival of adalimumab biosimilars to the originator for the treatment of psoriasis. A cohort study will be conducted using healthcare databases and pharmacovigilance registries from the UK, France, and Spain. The outcomes of interest are drug survival and risk of serious adverse events, and the results will be published by the end of 2023.

BMJ OPEN (2023)

Correction Geriatrics & Gerontology

Genetically downregulated Interleukin-6 signalling is associated with a lower risk of frailty (vol 52, afac318, 2023)

Niki Mourtzi, Marios K. Georgakis, Eva Ntanasi, Alexandros Hatzimanolis, Alfredo Ramirez, Stephanie Heilmann-Heimbach, Benjamin Grenier-Boley, Jean-Charles Lambert, Mary Yannakoulia, Mary Kosmidis, Efthimios Dardiotis, Giorgos Hadjigeorgiou, Paraskevi Sakka, Nikolaos Scarmeas

AGE AND AGEING (2023)

Letter Clinical Neurology

Association of MGMT and BIN1 genes with Alzheimer's disease risk across sex and APOE ε4 status

Julie Le Borgne, Philippe Amouyel, Ole Andreassen, Ruth Frikke-Schmidt, Mikko Hiltunen, Martin Ingelsson, Alfredo Ramirez, Giacomina Rossi, Agustin Ruiz, Pascual Sanchez-Juan, Rebecca Sims, Kristel Sleegers, Magda Tsolaki, Sven J. van der Lee, Julie Williams, Jean-Charles Lambert, Celine Bellenguez

ALZHEIMERS & DEMENTIA (2023)

Article Clinical Neurology

The first genome-wide association study in the Argentinian and Chilean populations identifies shared genetics with Europeans in Alzheimer's disease

Maria Carolina Dalmasso, Itziar de Rojas, Natividad Olivar, Carolina Muchnik, Barbara Angel, Sergio Gloger, Mariana Soledad Sanchez Abalos, Maria Victoria Chacon, Rafael Aranguiz, Paulina Orellana, Carolina Cuesta, Pablo Galeano, Lorenzo Campanelli, Gisela Vanina Novack, Luis Eduardo Martinez, Nancy Medel, Julieta Lisso, Zulma Sevillano, Nicolas Irureta, Eduardo Miguel Castano, Laura Montrreal, Michaela Thoenes, Claudia Hanses, Stefanie Heilmann-Heimbach, Claudia Kairiyama, Ines Mintz, Ivana Villella, Fabiana Rueda, Amanda Romero, Nancy Wukitsevits, Ivana Quiroga, Cristian Gona, Jean-Charles Lambert, Patricia Solis, Daniel Gustavo Politis, Carlos Alberto Mangone, Christian Gonzalez-Billault, Merce Boada, Lluis Tarraga, Andrea Slachevsky, Cecilia Albala, Patricio Fuentes, Silvia Kochen, Luis Ignacio Brusco, Agustin Ruiz, Laura Morelli, Alfredo Ramirez

Summary: This study is the first GWAS on Alzheimer's disease in a population from Argentina and Chile. A trans-ethnic meta-analysis revealed four new loci involving lysosomal function in AD. The genetic risk score developed in Europeans performed well in this population, but the score diminished with increasing Native American ancestry.

ALZHEIMERS & DEMENTIA (2023)

Meeting Abstract Genetics & Heredity

Unbiased estimation of the heritability associated with a binary trait, computed from a case-control study

Catherine Schramm, Simon Chenu, Celine Bellenguez, Benjamin Grenier-Boley, Jean-Francois Deleuze, Jean-Charles Lambert, Gael Nicolas, Herve Perdry, Camille Charbonnier

HUMAN HEREDITY (2022)

No Data Available